Jim Cramer Discusses TikTok Ban, President Trump & These 6 Stocks

4. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders In Q3 2024: 81

Johnson & Johnson (NYSE:JNJ) is one of the biggest healthcare companies in the world. Cramer has sporadically mentioned the stock in 2025. Some of his latest remarks surrounded Johnson & Johnson (NYSE:JNJ)’s intent to acquire neuropsychiatric medicine manufacturer Intra-Cellular for a $14.1 billion price tag. Cramer believes that Bristol-Myers’ medicines, which are similar to Intra-Cellular, merit a deeper look into the latter’s portfolio. This time around, he commented on Johnson & Johnson (NYSE:JNJ)’s decision to spin off its consumer health business Kenvue:

“You know some of these guys spin off these things, and like, well, no, I mean I think JNJ, Kenvue, I liked Kenvue. They think it kept the margins. . . “